Catalyst Biosciences, Inc. (CBIO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:24PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 11.34M |
| Enterprise value | -33.13M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.50 |
| Price/book (mrq) | 0.28 |
| Enterprise value/revenue | -4.51 |
| Enterprise value/EBITDA | 0.38 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.97 |
| 52-week change 3 | -91.37% |
| S&P500 52-week change 3 | -3.35% |
| 52-week high 3 | 5.2000 |
| 52-week low 3 | 0.3500 |
| 50-day moving average 3 | 0.5834 |
| 200-day moving average 3 | 1.9827 |
Share statistics
| Avg vol (3-month) 3 | 334.85k |
| Avg vol (10-day) 3 | 175.64k |
| Shares outstanding 5 | 31.48M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 21.46M |
| % held by insiders 1 | 11.94% |
| % held by institutions 1 | 41.13% |
| Shares short (28 Apr 2022) 4 | 332.06k |
| Short ratio (28 Apr 2022) 4 | 1.61 |
| Short % of float (28 Apr 2022) 4 | 1.06% |
| Short % of shares outstanding (28 Apr 2022) 4 | 1.05% |
| Shares short (prior month 30 Mar 2022) 4 | 526.97k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 12 Feb 2017 |
| Ex-dividend date 4 | 19 Aug 2015 |
| Last split factor 2 | 1:15 |
| Last split date 3 | 12 Feb 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Dec 2021 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,140.99% |
Management effectiveness
| Return on assets (ttm) | -69.54% |
| Return on equity (ttm) | -150.11% |
Income statement
| Revenue (ttm) | 7.34M |
| Revenue per share (ttm) | 0.24 |
| Quarterly revenue growth (yoy) | 20.10% |
| Gross profit (ttm) | -64.91M |
| EBITDA | -83.44M |
| Net income avi to common (ttm) | -87.93M |
| Diluted EPS (ttm) | -2.8700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 46.85M |
| Total cash per share (mrq) | 1.49 |
| Total debt (mrq) | 2.38M |
| Total debt/equity (mrq) | 5.80 |
| Current ratio (mrq) | 3.63 |
| Book value per share (mrq) | 1.31 |
Cash flow statement
| Operating cash flow (ttm) | -83.75M |
| Levered free cash flow (ttm) | -48.89M |
© 2022 Yahoo. All rights reserved.
